Pipeline
We’re developing novel protein therapeutics targeting inflammatory and degenerative diseases. The chart below shows the current stage of our programmes.
We’re developing novel protein therapeutics targeting inflammatory and degenerative diseases. The chart below shows the current stage of our programmes.